Lista de obras - Christian Rolfo - Dominio Público Uruguay

A Multicenter Study to Assess Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting

APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines

artículo científico publicado en 2016

Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward

artículo científico publicado en 2015

Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.

artículo científico publicado en 2017

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

artículo científico publicado en 2013

Biomarkers of response to immune checkpoint blockade in cancer treatment

artículo científico publicado en 2018

CSF-1 and Ang-2 serum levels - prognostic and diagnostic partners in non-small cell lung cancer.

artículo científico publicado en 2018

Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer

scientific article published on 29 April 2019

Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies

scientific article published on 08 March 2018

Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?

artículo científico

Evaluation of in vitro cytotoxicity, biocompatibility, and changes in the expression of apoptosis regulatory proteins induced by cerium oxide nanocrystals

artículo científico publicado en 2017

Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer

artículo científico publicado en 2017

Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy

artículo científico publicado en 2014

Fifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology Workshop

article

Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?

artículo científico publicado en 2018

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

artículo científico publicado en 2014

HER2 Mutations in Non-Small Cell Lung Cancer: A Herculean Effort to Hit the Target

artículo científico publicado en 2020

How I treat ALK-positive non-small cell lung cancer

artículo científico publicado en 2019

How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?

artículo científico publicado en 2014

Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines

artículo científico publicado en 2013

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.

artículo científico publicado en 2018

Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…

artículo científico publicado en 2017

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

artículo científico publicado en 2014

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

artículo científico publicado en 2014

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study

artículo científico publicado en 2020

Improving extracellular vesicles visualization: From static to motion

scientific article published on 16 April 2020

In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.

artículo científico publicado en 2017

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network

artículo científico publicado en 2018

Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study

artículo científico publicado en 2019

Liquid biopsies in lung cancer: the new ambrosia of researchers.

artículo científico publicado en 2014

Liquid biopsy for early stage lung cancer moves ever closer

artículo científico publicado en 2020

Looking for a new panacea in ALK-rearranged NSCLC: may be Ceritinib?

artículo científico publicado en 2014

Molecular Regulation of Cancer Cell Migration, Invasion, and Metastasis

artículo científico publicado en 2019

Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer

artículo científico publicado en 2014

Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential

artículo científico publicado en 2018

Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor

artículo científico

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.

artículo científico

Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

artículo científico publicado en 2018

Neoadjuvant trials can accelerate research on novel systemic treatment modalities in cancer of the uterine cervix

artículo científico publicado en 2017

New targets bring hope in squamous cell lung cancer: neurotrophic tyrosine kinase gene fusions.

artículo científico publicado en 2017

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.

artículo científico publicado en 2014

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.

artículo científico publicado en 2019

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

scientific article published on 02 March 2014

Pooled analysis of the surgical treatment for colorectal cancer liver metastases

artículo científico

Potential new biomarkers for squamous carcinoma of the uterine cervix.

artículo científico publicado en 2018

Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy

artículo científico publicado en 2020

Ramucirumab and its use in gastric cancer treatment.

artículo científico publicado en 2014

Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition

artículo científico publicado en 2017

Screening for epidermal growth factor receptor mutations in lung cancer

artículo científico publicado en 2009

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

scientific article published on 01 February 2020

Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice

scientific article published on 11 September 2020

TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy.

artículo científico publicado en 2013

TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value

artículo científico publicado en 2015

Targeted therapies in hepatocellular carcinoma.

artículo científico publicado en 2014

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option

artículo científico publicado en 2017

The role of targeted therapy for gastrointestinal tumors.

artículo científico publicado en 2014

The value of immunotherapy in head and neck cancer

artículo científico publicado en 2018

Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed.

artículo científico publicado en 2014

To Decipher the Mycoplasma hominis Proteins Targeting into the Endoplasmic Reticulum and Their Implications in Prostate Cancer Etiology Using Next-Generation Sequencing Data.

artículo científico publicado en 2018

Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine.

artículo científico publicado en 2018

Understanding EGFR heterogeneity in lung cancer

scientific article published on 01 October 2020

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation

scientific article published on 19 March 2018

Lista de obras de Christian Rolfo

A Multicenter Study to Assess Mutational Status in Plasma: Focus on an Optimized Workflow for Liquid Biopsy in a Clinical Setting

APR-246 (PRIMA-1(MET)) strongly synergizes with AZD2281 (olaparib) induced PARP inhibition to induce apoptosis in non-small cell lung cancer cell lines

Adjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step Forward

Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway.

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects.

Biomarkers of response to immune checkpoint blockade in cancer treatment

CSF-1 and Ang-2 serum levels - prognostic and diagnostic partners in non-small cell lung cancer.

Current knowledge of Ipilimumab and its use in treating non-small cell lung cancer

Effect of Primary Tumor Location on Second- or Later-line Treatment Outcomes in Patients With RAS Wild-type Metastatic Colorectal Cancer and All Treatment Lines in Patients With RAS Mutations in Four Randomized Panitumumab Studies

Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense?

Evaluation of in vitro cytotoxicity, biocompatibility, and changes in the expression of apoptosis regulatory proteins induced by cerium oxide nanocrystals

Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer

Farletuzumab for NSCLC: exploiting a well-known metabolic pathway for a new therapeutic strategy

Fifth Educational Symposium of the Spanish Lung Cancer Group: Report on the Molecular Biology Workshop

Gender and outcomes in non-small cell lung cancer: an old prognostic variable comes back for targeted therapy and immunotherapy?

Germline copy number variation in the YTHDC2 gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?

HER2 Mutations in Non-Small Cell Lung Cancer: A Herculean Effort to Hit the Target

How I treat ALK-positive non-small cell lung cancer

How to find the Ariadne's thread in the labyrinth of salvage treatment options for metastatic colorectal cancer?

Hypoxia and human genome stability: downregulation of BRCA2 expression in breast cancer cell lines

Hypoxia-Induced Cisplatin Resistance in Non-Small Cell Lung Cancer Cells Is Mediated by HIF-1α and Mutant p53 and Can Be Overcome by Induction of Oxidative Stress.

Immune checkpoint inhibitors in lung cancer: the holy grail has not yet been found…

Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy?

Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?

Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study

Improving extracellular vesicles visualization: From static to motion

In silico evaluation of DNA Damage Inducible Transcript 4 gene (DDIT4) as prognostic biomarker in several malignancies.

Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network

Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study

Liquid biopsies in lung cancer: the new ambrosia of researchers.

Liquid biopsy for early stage lung cancer moves ever closer

Looking for a new panacea in ALK-rearranged NSCLC: may be Ceritinib?

Molecular Regulation of Cancer Cell Migration, Invasion, and Metastasis

Molecular mechanisms underlying the role of microRNAs in the chemoresistance of pancreatic cancer

Molecular profiling of pancreatic neuroendocrine tumors (pNETS) and the clinical potential

Molecular target therapy for bone metastasis: starting a new era with denosumab, a RANKL inhibitor

Monoclonal antibodies for the treatment of non-haematological tumours: update of an expanding scenario.

Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer

Neoadjuvant trials can accelerate research on novel systemic treatment modalities in cancer of the uterine cervix

New targets bring hope in squamous cell lung cancer: neurotrophic tyrosine kinase gene fusions.

Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitors.

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker.

Phase I/II trial of vorinostat (SAHA) and erlotinib for non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations after erlotinib progression

Pooled analysis of the surgical treatment for colorectal cancer liver metastases

Potential new biomarkers for squamous carcinoma of the uterine cervix.

Precision Prevention and Cancer Interception: The New Challenges of Liquid Biopsy

Ramucirumab and its use in gastric cancer treatment.

Retinoic Acid affects Lung Adenocarcinoma growth by inducing differentiation via GATA6 activation and EGFR and Wnt inhibition

Screening for epidermal growth factor receptor mutations in lung cancer

Specialized Blood Collection Tubes for Liquid Biopsy: Improving the Pre-analytical Conditions

Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice

TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy.

TP53 and MDM2 genetic alterations in non-small cell lung cancer: Evaluating their prognostic and predictive value

Targeted therapies in hepatocellular carcinoma.

Targeting Angiogenesis in Biliary Tract Cancers: An Open Option

The role of targeted therapy for gastrointestinal tumors.

The value of immunotherapy in head and neck cancer

Thymidylate synthase polymorphisms in genomic DNA as clinical outcome predictors in a European population of advanced non-small cell lung cancer patients receiving pemetrexed.

To Decipher the Mycoplasma hominis Proteins Targeting into the Endoplasmic Reticulum and Their Implications in Prostate Cancer Etiology Using Next-Generation Sequencing Data.

Ultrafiltration and size exclusion chromatography combined with asymmetrical-flow field-flow fractionation for the isolation and characterisation of extracellular vesicles from urine.

Understanding EGFR heterogeneity in lung cancer

Unveiling a CD70-positive subset of cancer-associated fibroblasts marked by pro-migratory activity and thriving regulatory T cell accumulation